Active Ingredient(s):Melphalan Flufenamide FDA Approved: * February 26, 2021 Pharm Company: *ONCOPEPTIDES AB Category:Cancer
Melphalan, sold under the trade name Alkeran among others, is a chemotherapy medication used to treat multiple myeloma, ovarian cancer, melanoma, and AL amyloidosis. It is taken as a tablet (by mouth) or by injection into a vein.
Common side effects include nausea and bone marrow suppression. Other severe side effects may include anaphylaxis and the development of other cancers. Use during pregnancy may result in harm...
* May have multiple approval dates, manufacturers, or labelers.